Viewing Study NCT00698061


Ignite Creation Date: 2025-12-24 @ 12:31 PM
Ignite Modification Date: 2025-12-27 @ 9:32 PM
Study NCT ID: NCT00698061
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2008-06-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis B View
None Adjuvanted vaccine View